title: Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events.
authors.affiliation: US Outcomes Research, Merck, North Wales, Pennsylvania 19454, USA. swapnil.rajpathak@merck.com
authors.forename: Swapnil N
authors.initials: SN
authors.lastname: Rajpathak